Their group, the Society for Perioperative Assessment and Quality Improvement (SPAQI), released their own multidisciplinary consensus guidelines along with a review of the current evidence
The compounding pharmacies that supply telehealth companies arent giving up on this lucrative revenue stream without a fight
This widespread off-label use creates specific legal questions about: Whether patients received adequate warnings Whether doctors were properly informed of risks Whether marketing encouraged inappropriate use Wegovy (Weight Management Medication) FDA-Approved Use: Chronic weight management in adults with obesity (BMI 30) Chronic weight management in adults with overweight (BMI 27) who have weight-related conditions Dosing Schedule: Slower escalation schedule over 16-20 weeks Starting dose: 0.25 mg weekly Gradual increases: 0.5 mg 1.0 mg 1.7 mg Maximum dose: 2.4 mg weekly (higher than Ozempic) Intended Primary Effect: Weight loss Body weight reduction of 15%+ on average Additional Considerations: Typically requires obesity or overweight diagnosis May be covered by insurance for weight management Clinical trials specifically measured weight loss outcomes Critical Legal Distinctions Even though Ozempic and Wegovy are the same drug, in lawsuits your exact prescription matters significantly : 1
Araszkiewicz A, Bandurska-Stankiewicz E, Budzyski A, et al
For some patients, GLP-1 injections offer fewer side effects while still achieving optimal results than other weight loss injections
Testing frequency should increase during active compound use
